Sign in

CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company

Greenwich LifeSciences, Inc.

Sign in to watch
Ticker
GLSI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
205473709
Phone
203-434-3290
Business address
3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-29 McWilliams David Director Option exercise · Series A Preferred Stock −152,604 0
2020-09-29 McWilliams David Director Option exercise · Series B Preferred Stock −7,663 0
2020-09-29 McWilliams David Director Option exercise · Series C Preferred Stock −3,746 0
2020-09-29 McWilliams David Director Option exercise · Series D Preferred Stock −6,555 0
2020-09-29 McWilliams David Director Other acquisition · Series D Preferred Stock +1,054 1,054
2020-09-29 McWilliams David Director Option exercise · Series D Preferred Stock −1,054 0
2020-09-29 Hallock Kenneth Director Purchase +74,782 $5.75 $430K 257,368
2020-09-29 Patel Snehal CEO and CFO Purchase +114,347 $5.75 $657K 863,683
2020-09-29 Daugherty Frank Joseph Chief Medical Officer Purchase +1,739 $5.75 $10K 86,010
2020-09-29 McWilliams David Director Purchase +2,608 $5.75 $15K 446,979

Page 10 of 10 · 190 trades